Try our Advanced Search for more refined results

Shire Development, LLC et al v. Mylan Pharmaceuticals, Inc. et al

  1. June 15, 2017

    Fed. Circ. Ruling Clears Judge To OK Mylan's Lialda Generic

    A Florida federal judge Wednesday reversed course and allowed Mylan NV to move ahead on a planned generic of Shire Development LLC's bowel disease drug Lialda, concluding a newer Federal Circuit decision required her to vacate her earlier patent infringement finding.

  2. December 02, 2013

    Shire Fires Back At Mylan's Grab For Docs In Patent Row

    Irish pharmaceutical company Shire Development LLC objected on Monday to Mylan Pharmaceuticals Inc.'s effort to obtain confidential documents in a patent infringement suit, arguing the materials contain third parties' confidential information and are tangential to the case.

  3. May 30, 2012

    Shire Looks To Quash Mylan's Generic Colitis Drug

    Irish pharmaceutical company Shire Development LLC on Monday hit Mylan Pharmaceuticals Inc. with a patent suit in Florida federal court, launching another attack against a generic-drug maker attempting to produce its own version of the ulcerative colitis drug Lialda.